Biosig Technologies, Common Stock Market Value

BSGM Stock  USD 1.93  0.06  3.21%   
BioSig Technologies,'s market value is the price at which a share of BioSig Technologies, trades on a public exchange. It measures the collective expectations of BioSig Technologies, Common investors about its performance. BioSig Technologies, is selling at 1.93 as of the 23rd of November 2024; that is 3.21 percent up since the beginning of the trading day. The stock's lowest day price was 1.56.
With this module, you can estimate the performance of a buy and hold strategy of BioSig Technologies, Common and determine expected loss or profit from investing in BioSig Technologies, over a given investment horizon. Check out BioSig Technologies, Correlation, BioSig Technologies, Volatility and BioSig Technologies, Alpha and Beta module to complement your research on BioSig Technologies,.
Symbol

Please note, there is a significant difference between BioSig Technologies,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if BioSig Technologies, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioSig Technologies,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

BioSig Technologies, 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioSig Technologies,'s otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioSig Technologies,.
0.00
12/04/2022
No Change 0.00  0.0 
In 1 year 11 months and 22 days
11/23/2024
0.00
If you would invest  0.00  in BioSig Technologies, on December 4, 2022 and sell it all today you would earn a total of 0.00 from holding BioSig Technologies, Common or generate 0.0% return on investment in BioSig Technologies, over 720 days. BioSig Technologies, is related to or competes with Neuropace, Inogen, SurModics, Pulmonx Corp, Apyx Medical, Neuroone Medical, and Biomerica. BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company More

BioSig Technologies, Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioSig Technologies,'s otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioSig Technologies, Common upside and downside potential and time the market with a certain degree of confidence.

BioSig Technologies, Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for BioSig Technologies,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioSig Technologies,'s standard deviation. In reality, there are many statistical measures that can use BioSig Technologies, historical prices to predict the future BioSig Technologies,'s volatility.
Hype
Prediction
LowEstimatedHigh
0.091.8715.28
Details
Intrinsic
Valuation
LowRealHigh
0.071.3114.72
Details
Naive
Forecast
LowNextHigh
0.031.5915.00
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-0.221.112.45
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as BioSig Technologies,. Your research has to be compared to or analyzed against BioSig Technologies,'s peers to derive any actionable benefits. When done correctly, BioSig Technologies,'s competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in BioSig Technologies,.

BioSig Technologies, Backtested Returns

BioSig Technologies, is out of control given 3 months investment horizon. BioSig Technologies, secures Sharpe Ratio (or Efficiency) of 0.23, which signifies that the company had a 0.23% return per unit of risk over the last 3 months. We were able to analyze and collect data for thirty different technical indicators, which can help you to evaluate if expected returns of 3.08% are justified by taking the suggested risk. Use BioSig Technologies, Risk Adjusted Performance of 0.1844, mean deviation of 8.05, and Downside Deviation of 12.11 to evaluate company specific risk that cannot be diversified away. BioSig Technologies, holds a performance score of 18 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -0.66, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning BioSig Technologies, are expected to decrease at a much lower rate. During the bear market, BioSig Technologies, is likely to outperform the market. Use BioSig Technologies, sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change , to analyze future returns on BioSig Technologies,.

Auto-correlation

    
  -0.2  

Insignificant reverse predictability

BioSig Technologies, Common has insignificant reverse predictability. Overlapping area represents the amount of predictability between BioSig Technologies, time series from 4th of December 2022 to 29th of November 2023 and 29th of November 2023 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioSig Technologies, price movement. The serial correlation of -0.2 indicates that over 20.0% of current BioSig Technologies, price fluctuation can be explain by its past prices.
Correlation Coefficient-0.2
Spearman Rank Test0.25
Residual Average0.0
Price Variance1.25

BioSig Technologies, lagged returns against current returns

Autocorrelation, which is BioSig Technologies, otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BioSig Technologies,'s otc stock expected returns. We can calculate the autocorrelation of BioSig Technologies, returns to help us make a trade decision. For example, suppose you find that BioSig Technologies, has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

BioSig Technologies, regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BioSig Technologies, otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BioSig Technologies, otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BioSig Technologies, otc stock over time.
   Current vs Lagged Prices   
       Timeline  

BioSig Technologies, Lagged Returns

When evaluating BioSig Technologies,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BioSig Technologies, otc stock have on its future price. BioSig Technologies, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BioSig Technologies, autocorrelation shows the relationship between BioSig Technologies, otc stock current value and its past values and can show if there is a momentum factor associated with investing in BioSig Technologies, Common.
   Regressed Prices   
       Timeline  

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in BioSig OTC Stock

BioSig Technologies, financial ratios help investors to determine whether BioSig OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioSig with respect to the benefits of owning BioSig Technologies, security.